Form D Explorer

Form C — EMulate Therapeutics, Inc.

0001254348-25-000003 · filed Oct 8, 2025 · via Wefunder Portal LLC

Offering

Target
$50,000
Maximum
$1,235,000
Security type
Common Stock
Price per security
$10.5400
Deadline
—
Oversubscription
Accepted

Issuer

CIK
1254348
Entity
Corporation
Jurisdiction
WA
Address
2620 Bellevue Way NE
Bellevue, WA 98004
Phone
—

Most recent fiscal year financials

Total assets
$1,193,000
Cash
—
Short-term debt
$30,988,000
Long-term debt
$5,655,000
Revenues
—
COGS
—
Taxes paid
—
Net income
$-19,139,000

View the original filing on SEC EDGAR ↗